Maximizing Survival Potential in Very High Risk Cardiac Surgery

Heart Failure Clinics

Volumn 3, Issue 2, 2007, Pages 159-180

  Westaby, Stephen ^a   Balacumaraswami, L ^a   Sayeed, R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; DOPAMINE; MILRINONE; NITRIC OXIDE; NORADRENALIN;

ASSISTED CIRCULATION; BLOOD PUMP; CORONARY RISK; DRUG MEGADOSE; FORWARD HEART FAILURE; HEART DISEASE; HEART PROTECTION; HEART SURGERY; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; LUNG VASCULAR RESISTANCE; PATIENT CARE; PATIENT IDENTIFICATION; PATIENT SELECTION; POSTOPERATIVE PERIOD; REVIEW; SURVIVAL; TREATMENT INDICATION;

ADMINISTRATION, INHALATION; ASSISTED CIRCULATION; BRONCHODILATOR AGENTS; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HUMANS; NITRIC OXIDE; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 34447515624     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.05.001     Document Type: Review

References (98)

1. O'Connor G.T., Birkmeyer J.D., Dacey L.J., et al. Results of a regional study of modes of death associated with coronary artery bypass grafting. Ann Thorac Surg 66 (1998) 1323-1328
2. Marso S.P., Bhatt D.L., Roe M.T., et al. Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. Circulation 102 (2000) 2952-2958
3. Liu J.Y., Birkmeyer N.J.O., and Sanders J.H. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation 102 (2000) 2973-2977
4. Connolly H.M., Oh J.K., Schaff H.V., et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation 102 (2000) 2952-2958
5. Mariani J., Ou R., Bailey M., et al. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg 120 (2000) 660-667
6. Goldstein D.J., and Oz M.C. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg 12 3 (2000) 220-228
7. Smedira N.G., and Blackstone E.H. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 71 3 Suppl (2001) S60-S66
8. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 (1999) 609-634
9. Bavaria J.E., Furukawa S., Kreiner G., et al. Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg 100 (1990) 210-220
10. Krause S.M., Jacobus W.E., and Becker L.C. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischaemic "stunned" myocardium. Circ Res 65 (1989) 526-530
11. Furukawa S., Bavaria J.E., Kreiner G., et al. Relationship between total mechanical energy and oxygen consumption in the stunned myocardium. Ann Thorac Surg 49 (1990) 543-548
12. 2+ transients underlie stunning?. Circ Res 66 (1990) 1268-1276
13. Korvald C, Elvenes OP, Ytrebo LM, et al. Oxygen-wasting effect of inotropy in the "virtual work model". Am J Physiol 1999;276:H1339-45.
14. Bavaria J.E., Furukawa S., Kreiner G., et al. Effect of circulatory assist devices on stunned myocardium. Ann Thorac Surg 49 1 (1990) 123-128
15. 2+ sensitisation and PDE III-inhibition as energy consumption. Eur J Cardiothorac Surg 18 (2000) 83-89
16. Ellis S.G., Wynne J., Braunwald E., et al. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 107 (1984) 13-19
17. Laxter S.B., Becker L.C., Ambrosio G., et al. Reduced aerobic metabolic efficiency in globally stunned myocardium. J Mol Cell Cardiol 21 (1989) 419-426
18. Suga H., Hisano R., Goto Y., et al. Effects of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 53 (1983) 306-318
19. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 66 (1992) 1146-1149
20. Bolli R. Mechanism of myocardial stunning. Circulation 82 (1990) 723-738
21. Ito B.R., Tate H., Kobayashi M., et al. Reversibly injured, postischemic canine myocardium retains normal contractile reserve. Circ Res 61 (1987) 834-846
22. Myens B., Sergeant P., Wouters P., et al. Mechanical support with microaxial blood pumps for postcardiotomy left ventricular failure: can outcome be predicted?. J Thorac Cardiovasc Surg 120 (2000) 393-400
23. Burkhoff D. Myocardial energetics and the postischemic heart. Ann Thorac Surg 49 (1990) 525-527
24. Liedtke A.J., De Maison L., Eggleston A.M., et al. Changes in substrate metabolism and effects of excess fatty acid in reperfused myocardium. Circ Res 62 (1988) 535-542
25. Fowler M.B., Laser J.A., Hopkins G.L., et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74 6 (1986) 1290-1302
26. Shan K., Bick R.J., Poindexter B.J., et al. Altered adrenergic receptor density in myocardial hibernation in humans. Circulation 102 (2000) 2599-2606
27. Lohse M.J., Engelhardt S., Danner S., et al. Mechanisms of beta-adrenergic receptor desensitisation: from molecular biology to heart failure. Basic Res Cardiol 91 Suppl 2 (1996) 29-34
28. Gerhardt M.A., Booth J.V., Chesnut L.C., et al. Acute desensitisation of myocardial β adrenergic receptors during cardiopulmonary bypass. Circulation 84 (1991) 2559-2567
29. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., et al. Mechanical unloading restores β adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
30. Westaby S. League tables, risk assessment and an opportunity to improve standards. Br J Cardiol (Acute Interv Cardiol) 9 (2002) 5-10
31. Shahian D.M., Normand S.L., Torchiana D.F., et al. Cardiac surgery report cards, comprehensive review and statistical critique. Ann Thorac Surg 68 (1999) 1195-1202
32. Rao V., Ivanov J., Weisel R.D., et al. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 112 1 (1996) 38-51
33. Tomasco B., Cappiello A., Fiorilli R., et al. Surgical revascularisation for acute coronary insufficiency: analysis of risk factors for hospital mortality. Ann Thorac Surg 64 (1997) 678-683
34. Flack J.E., Cook J.R., May S.J., et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch trial. Circulation (2000) 102(19 Suppl 3) 111:84-89
35. Ibrahim M.F., Venn G.E., Young C.P., et al. A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution. Eur J Cardiothorac Surg 15 1 (1999) 75-83
36. Kalawski R., Balinski M., Bugajski P., et al. Stimulation of neutrophil activation during coronary artery bypass grafting: comparison of crystalloid and blood cardioplegia. Ann Thorac Surg 71 (2001) 827-831
37. Kalawski R., Deskur E., Bugajski P., et al. Stimulation of neutrophil integrin expression during coronary artery bypass grafting: comparison of crystalloid and blood cardioplegia solutions. J Thorac Cardiovasc Surg 119 6 (2000) 1270-1277
38. Christakis G.T., Weisel R.D., Fremes S.E., et al. Coronary artery bypass surgery in patients with poor ventricular function. J Thorac Cardiovasc Surg 103 (1992) 1083-1092
39. Elveres O.P., Korvald C., Ytrebo L.M., et al. Myocardial metabolism and efficiency after warm continuous blood cardioplegia. Ann Thorac Surg 69 (2000) 1799-1805
40. The Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 343 8897 (1994) 559-563
41. Fremes S.F., Tamaritz M.G., Abramov D., et al. Late results of the Warm Heart Trial. The influence of non fatal cardiac events on late survival. Circulation (2000) 102(19 Suppl 3):111:339-45
42. Mallidi H.R., Sever J., Tamariz M., et al. The short-term and long-term effects of warm or tepid cardioplegia. J Thorac Cardiovasc Surg 125 3 (2003) 711-720
43. Teoh K.H., Christakis G.T., Weisel R.D., et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia (hot shot). J Thorac Cardiovasc Surg 91 (1986) 888-895
44. Menasché P., Subayi J.B., Veyssié L., et al. Efficacy of coronary sinus cardioplegia in patients with complete coronary artery occlusions. Ann Thorac Surg 51 (1991) 418-423
45. Kaul T.K., Agnihotri A.K., Fields B.L., et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 111 5 (1996) 1001-1012
46. Borger M.A., Rao V., Weisel R.D., et al. Reoperative coronary bypass surgery: effect of patent grafts and retrograde cardioplegia. J Thorac Cardiovasc Surg 121 1 (2001) 83-90
47. The Warm Heart Investigators. Normothermic versus hypothermic cardiac surgery: a randomized trial in 1732 coronary bypass patients. Lancet 343 (1994) 559-563
48. Cohen G., Borger M.A., Weisel R.D., et al. Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg 68 5 (1999) 1995-2001
49. Lazar H.L., Buckberg G.D., Manganaro A.J., et al. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 80 (1980) 350-359
50. Ericsson A.B., Takeshima S., and Vaage J. Simultaneous antegrade and retrograde delivery of continuous warm blood cardioplegia after global ischemia. J Thorac Cardiovasc Surg 115 3 (1998) 716-722
51. Lazar H.L., Buckberg G.D., Foglia R.P., et al. Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass. J Thorac Cardiovasc Surg 82 (1981) 18-25
52. Marra C., De Santo L.S., Amarelli C., et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomized study on the timing of perioperative intraaortic balloon pump support. Int J Artif Organs 25 (2002) 141-146
53. Christenson J.T., Simonet F., Badel P., et al. Optimal timing of preoperative intra-aortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 68 (1999) 934-939
54. Powell W.J., Daggett W.M., Magro A.E., et al. Effects of intra-aortic balloon pump counterpulsation on cardiac performance, oxygen consumption and coronary blood flow in dogs. Circ Res 26 (1970) 753-755
55. Christenson J.T., Cohen M., Ferguson III J.J., et al. Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann Thorac Surg 74 (2002) 1086-1091
56. Lim C.H., Son H.S., Baek K.J., et al. Comparison of coronary artery blood flow and hemodynamic energy in a pulsatile pump versus a combined nonpulsatile pump and an intra-aortic balloon pump. ASAIO J 52 5 (2006) 595-597
57. Dietl C.A., Berkheimer M.D., Woods E.L., et al. Efficacy and cost effectiveness of pre-operative intra-aortic balloon pump patients with ejection fraction of 0.25 or less. Ann Thorac Surg 62 (1996) 401-408
58. Baldwin R.T., Slogoff S., Noon G.P., et al. A model to predict survival at time of postcardiotomy intra aortic balloon pump insertion. Ann Thorac Surg 55 (1993) 908-913
59. Christenson J.T., Simonet F., Badel P., et al. The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left ventricular function (LVEF < 40%) and hypertensive LV hypertrophy. Thorac Cardiovasc Surg 45 2 (1997) 60-64
60. Torchiana D.F., Hirsch G., Buckley M.J., et al. Intra-aortic balloon pumping for cardiac support: trends in practice and outcome 1968-1995. J Thorac Cardiovasc Surg 113 4 (1997) 758-769
61. Ferguson J.J., Cohen M., Freedman R.J., et al. The current practice of intra-aortic balloon counterpulsation. Results from the Benchmark Registry. J Am Coll Cardiol 38 (2001) 1456-1462
62. Christenson J.T., Cohen M., Ferguson J.J., et al. Society of Thoracic Surgeons (USA) National Database. Trends in intra-aortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann Thorac Surg 74 (2002) 1086-1091
63. Busch T, Sirbu H, Zenker D, et al. Vascular complications related to intra-aortic counterpulsation: an analysis of a 10-year experience. Thoracic Cardiovascular Surgery 1997; 45:55-9.
64. Ivanov J., Weisel R.D., David T.E., et al. Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation 97 7 (1998) 673-680
65. Yau T.M., Fedak P.W.M., Weisel R.D., et al. Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. J Thorac Cardiovasc Surg 118 6 (1999) 1006-1013
66. Wechsler A.S. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 111 (1996) 998-1000
67. Gutfinger D.E., Ott R.A., Miller M., et al. Aggressive pre-operative use of intra-aortic balloon pump in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg 67 (1999) 610-613
68. Baskett R.J., O'Connor G.T., Hirsch G.M., et al. A multi-center comparison of intra-aortic balloon pump in isolated coronary bypass graft surgery. Ann Thorac Surg 76 6 (2003) 1988-1992
69. Holman W., Qing L., Kiefe C., et al. Prophylactic value of precision intra-aortic balloon pump: analysis of a statewide experience. J Thorac Cardiovasc Surg 120 (2000) 1112-1119
70. Wessel D.L., Adatia I., Giglia M., et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88 (1993) 2128-2138
71. Fullerton D.A., and McIntyre Jr. R.C. Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery. Ann Thorac Surg 61 (1996) 1856-1864
72. Fullerton D.A., Jones S.D., Jaggers J., et al. Effective control of pulmonary vascular resistance with inhaled nitric oxide following cardiac operation. J Thorac Cardiovasc 111 (1996) 753-763
73. Girard C., Lehot J.J., Pannetier J.C., et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary hypertension. Anesthesiology 77 (1992) 880-883
74. Fullerton D.A., Jaggers J., Wollmering M., et al. Variable response to inhaled nitric oxide following cardiac surgery. Ann Thorac Surg 63 (1997) 1251-1256
75. Fullerton D.A., McIntyre Jr. R.C., Hahn A.R., et al. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin induced acute lung injury. Am J Physiol 268 (1995) L1029-L1035
76. Fullerton D.A., Jaggers J., Piedalue F., et al. Effective control of refractory pulmonary hypertension after cardiac surgery. J Thorac Cardiovasc Surg 113 (1997) 365-368
77. Argenziano M., Choudhri A.F., Moazami N., et al. Randomised double blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 65 (1998) 340-345
78. Kieler-Jenson N., Lundin S., and Ricksten S.E. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide, and intravenous prostacyclin, prostaglandin E, and sodium nitroprusside. J Heart Lung Transplant 14 (1995) 436-443
79. Aaronson K.D., Patel H., and Pagani F.D. Patient selection for left ventricular assist device therapy. Ann Thorac Surg 75 (2003) S29-S35
80. Taylor D.O., Edwards L.B., Bouck M.M., et al. Registry of The International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report-2006. J Heart Lung Transplant 25 (2006) 869-879
81. Oz M.C., Goldstein D.J., Pepino P., et al. Screening scale predicts patients successfully receiving long term implantable left ventricular assist devices. Circulation 92 Suppl II (1995) II169-II173
82. Entwistle J.W.C. Short and long term mechanical ventricular assistance towards myocardial recovery. Surg Clin North Am 84 (2004) 201-221
83. Samuel L.E., Holmes E.C., Thomas M.P., et al. Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg 71 (2001) S67-S72
84. Jett G.K. Postcardiotomy support with ventricular assist devices; selection of recipients. Semin Thorac Cardiovasc Surg 6 (1994) 136-139
85. Guyton R.A., Schonberger J., Everts P., et al. Post cardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg 56 (1993) 346-356
86. Samuels L.E., Kaufman M.S., Thomas M.P., et al. Pharmacologic criteria for ventricular assist device insertion: experience with the ABIOMED BVS 5000. J Card Surg 14 (1999) 288-293
87. Farrar D.J. The Thoratec ventricular assist device: a paracorporeal pump for treating acute and chronic heart failure. Semin Thorac Cardiovasc Surg 12 (2000) 243-250
88. Hetzer R., Potapov E.V., Stiller B., et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg 82 3 (2006) 917-925
89. Arabia F.A., Tsau P.A., Smith R.G., et al. Pediatric bridge to heart transplantation: application of the Berlin Heart, Medos and Thoratec ventricular assist devices. J Heart Lung Transplant 25 1 (2006) 16-21
90. Frazier O.H., Rose E.A., McCarthy P., et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Thorac Surg 222 (1995) 327-328
91. Jett G.K. ABIOMED BVS 5000: experience and potential advantages. Ann Thorac Surg 61 (1996) 301-304
92. Hoy F.B.Y., Mueller D.K., Geiss D.M., et al. Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps?. Ann Thorac Surg 70 (2000) 1259-1263
93. Pae Jr. W.E., Miller C.A., Matthews Y., et al. Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg 104 3 (1992) 541-552
94. Golding L.A., Crouch R.D., Stewart R.W., et al. Postcardiotomy centrifugal mechanical ventricular support. Ann Thorac Surg 54 6 (1992) 1059-1063
95. Lee W.A., Gillinov A.M., Cameron D.E., et al. Centrifugal ventricular assist device for support of the failing heart after cardiac surgery. Crit Care Med 21 8 (1993) 1186-1191
96. Imasaka K., Masuda M., Oishi T., et al. Mechanical cardiac support system for patients with postcardiotomy cardiogenic shock: analysis of risk factors for survival. Jpn J Thorac Cardiovasc Surg 52 4 (2004) 163-168
97. DeRose Jr. J.J., Umana J.P., Argenziano M., et al. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices. Ann Thorac Surg 64 6 (1997) 1757-1762
98. Westaby S., Balacumaraswami L., Evans B.J., et al. Elective transfer from cardiopulmonary bypass to centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg 133 2 (2007) 577-578